‘COVID-19’ is most likely top of the agenda at many a management meeting these days.
The impact of the coronavirus outbreak on businesses is far reaching and perhaps we will only see its full impact in the months and years to come, not to mention the outcomes of a potential second wave.
All the more reason not to take our eye off the ball yet, says Rachel Davenport, Commercial Director at AlphaBiolabs – a company specialising in COVID-19, DNA, drug and alcohol testing for workplaces, members of the public and the legal sector.
Although businesses have begun to reopen their doors, juggling the requirements of social distancing and increased sanitation against operational and productivity targets is a big undertaking, alongside what was at one time, already a busy day job.
Continue reading for FREE!
Sign up for a myGrapevine account to get:
- Unlimited access to News content
- The latest Features, Columns & Opinions
- A full range of specialist HR newsletters to choose from
UK
United States


